A made-in Canada COVID-19 vaccine is said to be showing promising trial results.
The Medicago vaccine is showing showing positive antibody results in its Phase 2 trial, and may even be ready for a final authorization from Health Canada this summer.
While the results are not yet peer-reviewed, Medicago's Executive Vice-President for Scientific and Medical Affairs Nathalie Landry says other vaccines in use showed a similar correlation between the amount of antibodies produced and their effectiveness against the virus.
A Phase Three clinical trial is underway in Canada, the United States and the United Kingdom, with 30,000 participants.
Since a large percentage of Canadians will be fully vaccinated by the end of the summer, Landry says there are talks about testing if Medicago can be mixed and matched with other vaccines as a booster shot.
Welland CAO Optimistic for 2026
Niagara Clinics Help Coughs, Colds
Clifton Hill Construction in January
Gas Prices to Hold Steady: Analyst
NRP Using Warrant in Niagara Falls Area
Part of Welland Canal Officially Named
Girl Assaulted in Break and Enter
Invest in Officer Well-Being: Former Chair